About
Technology
Issues
FAQ
Links
Official Page
Should myeloid and lymphoid neoplasms with
PCM
1‐
JAK
2
and other rearrangements of
JAK
2
be recognized as specific entities?
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.